U.S. health officials have advised patients to pause the Ixchiq vaccine after reports of serious adverse events. Investigations are ongoing as the FDA reassesses its safety for older adults.
The FDA has approved the first at-home cervical cancer screening test, the Teal Wand, developed by Teal Health. This less invasive option aims to make screenings more accessible and comfortable for women, potentially eradicating cervical cancer in our lifetime.
The FDA has approved the Teal Wand, the first at-home alternative to Pap smears, offering a painless and convenient way for women to screen for cervical cancer. With the aim of increasing screening rates, this innovative device allows women to collect samples at home and mail them for lab testing.
The FDA has approved an innovative at-home cervical cancer screening tool, allowing women to self-collect samples and mail them for HPV testing, making screenings more accessible and comfortable.
Moderna's combined Covid and flu vaccine has outperformed traditional shots in a recent phase 3 trial, generating higher antibody levels and showing promise for dual protection against both viruses.
In a surprising move, President Trump has selected Dr. Casey Means as the new U.S. Surgeon General, replacing Dr. Janette Nesheiwat. Means, a wellness influencer and author, aims to tackle America's chronic disease epidemic with a fresh approach. Learn more about her controversial views and plans.
In a surprising turn, the Trump administration has requested a federal judge to dismiss a lawsuit aimed at restricting access to the abortion pill mifepristone, aligning with the Biden administration's stance. This case holds significant implications for abortion rights and reproductive health access.
The US health department's new requirement for placebo testing on vaccines has sparked debate among experts, who warn it could slow vaccine access and raise ethical issues. What does this mean for your health?
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
New research reveals semaglutide, the active ingredient in Wegovy, shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease affecting millions. The study indicates significant improvements in liver health among participants, leading to hopes for FDA approval.
